Tagged CYCN


Ironwood Files Form 10 for Cyclerion

          , 2019 Dear Future Cyclerion Shareholder:         On behalf of the entire Cyclerion team, I am pleased to welcome you as a future shareholder of our new company.         Cyclerion will be a clinical-stage biopharmaceutical company focused on harnessing the full therapeutic potential of nitric oxide signaling through development of next-generation soluble guanylate cyclase, or sGC, stimulators….